According to the report, Jinxin Fertility has good prospects...
According to the report, Jinxin Fertility has good prospects for business recovery. The company's development momentum is positive, demand for assisted reproduction is rigid, and it has high-quality growth on a global scale. However, risks such as new business expansion, health insurance fee control exceeding expectations, and medical accidents still require attention.
Guoxin Securities: Maintaining Jinxin Reproduction (01951) “Buy” Rating Strong Recovery in the Greater Bay Area ARS Initial Diagnosis and Egg Freezing Business
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment